Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer

Abstract

The past decade of lung cancer research has seen rapid advances in early detection and treatment and many new Food and Drug Administration–approved therapies for lung cancer. This has largely been possible because of clinical trials. Therapeutic, interventional clinical trials have become a critical component of lung cancer care. The National Comprehensive Cancer Network, the American Society of Clinical Oncology, and the European Society for Medical Oncology guidelines support clinical trial enrollment as standard of care for people with advanced-stage NSCLC and extensive-stage SCLC in first- and subsequent-line settings.